What Is Morgellons Disease? Symptoms & Treatment

Morgellons disease is a controversial skin condition in which people develop slow-healing sores and report unusual fibers or filaments emerging from their skin. Patients describe intense crawling, itching, and stinging sensations, often accompanied by small colored fibers visible under magnification. Whether Morgellons represents a distinct physical illness or a form of delusional infestation remains one of the most heated debates in dermatology, with credible researchers on both sides presenting strikingly different evidence.

What Morgellons Feels Like

The hallmark symptoms are hard to ignore. People with Morgellons describe crawling sensations under the skin, intense itching, and a feeling of something trying to push through the skin from the inside out. Lesions appear spontaneously, heal slowly, and often leave darkened scars. On and around these wounds, patients find unusual materials: seed-like objects, tiny black specks the size of coffee grounds, and clumps that look like fuzz balls sitting on otherwise intact skin.

The defining feature is the fibers themselves. Under a handheld magnifier at 30 to 60 times magnification, red, blue, black, and white fibers become visible. Some look like straight hollow tubes, others like wiry tangled threads. The black specks, when examined under an electron microscope, turn out to be tightly woven balls of black fibers. Patients also report thicker, translucent fibers embedded in their lesions that resist being pulled out. These fibers are what set Morgellons apart from other skin conditions and what make it so polarizing.

The Core Debate: Physical Disease or Psychiatric Condition

The medical community is deeply split on what causes Morgellons, and the two dominant explanations are nearly opposite.

The CDC’s Position

The largest government study on Morgellons was published by the CDC in 2012. After examining patients in Northern California, researchers found no common underlying medical condition or infectious source. No parasites or mycobacteria were detected in skin samples. Most of the materials collected from participants’ skin were composed of cellulose, likely cotton from clothing or the environment. The CDC concluded that the condition was similar to “more commonly recognized conditions such as delusional infestation,” a psychiatric condition where a person believes their body is infested with organisms despite no medical evidence of infection.

This view is shared by much of mainstream dermatology and psychiatry. One overview published through the National Institutes of Health stated plainly that Morgellons “is considered part of delusional infestation and is not a distinct condition,” pointing to the fact that patients’ symptoms often resolve with antipsychotic medication. The same review noted that case reports surged after 2002, when information about the condition spread online, leading some clinicians to describe it as one of the first illnesses “socially transmitted over the internet.”

The Infectious Disease Theory

Other researchers have pushed back forcefully. A growing body of peer-reviewed work links Morgellons to infection with Borrelia burgdorferi, the bacterium that causes Lyme disease. In one study of 25 Morgellons patients, spirochetes (the corkscrew-shaped bacteria characteristic of Lyme) were detected in 24 of them using a combination of culture, histology, and DNA testing. The bacteria were cultured from blood in seven patients and from vaginal secretions in three, indicating systemic infection rather than surface contamination. A separate case series found that nearly 97% of 122 Morgellons patients either tested positive for Lyme disease antigens or met clinical diagnostic criteria for it.

A clinical evaluation of 1,000 Lyme-positive patients found that 6% also had Morgellons. Among those 60 patients, tick-borne coinfections were common: 62% tested positive for Babesia (a parasite that infects red blood cells), 25% for Bartonella, 25% for Rickettsia, and 15% for Ehrlichia. Nearly half had multiple coinfections alongside their Lyme diagnosis. Researchers in this camp argue that Morgellons is “a true somatic illness associated with Borrelia infection, and not a delusional disorder,” noting that a similar skin condition has been documented in cattle and dogs.

What the Fibers Are Made Of

The composition of the fibers is itself contested. The CDC study identified them as cellulose, most likely cotton. But independent histological analysis tells a different story. Researchers who examined skin biopsies from Morgellons patients found that the dermal filaments were composed of keratin and collagen, two proteins the body naturally produces. The filaments stained predominantly for collagen, and when keratin was present, it appeared in irregular patches. The researchers concluded that the fibers resulted from abnormal activation of keratinocytes and fibroblasts, the cells responsible for building skin and connective tissue.

This distinction matters. If the fibers are environmental cotton, they could be sticking to open wounds or being introduced through scratching, which supports the delusional infestation model. If they are keratin and collagen produced by the body’s own cells, something is driving an abnormal biological process in the skin, which supports Morgellons as a distinct dermatological condition.

How Morgellons Is Treated

Treatment depends entirely on which explanation a clinician favors, and patients often find themselves caught between two very different approaches.

Psychiatric Treatment

Dermatologists who view Morgellons as a form of delusional infestation typically prescribe low-dose antipsychotic medications. Pimozide was historically the favored option, partly because it also helps reduce itching. More recently, clinicians have reported success with other antipsychotics at very low doses. In one case series, patients achieved 50% to 90% improvement at an average dose of about 2 mg per day and remained in remission for an average of 10 months. For patients willing to try this approach, symptom relief can be significant, including resolution of both the skin sensations and the appearance of fibers.

Antibiotic Treatment

Practitioners who view Morgellons as an infection-driven condition treat it with antibiotics targeting Borrelia. Some clinicians use a 14-day course of doxycycline, following CDC guidelines for cutaneous Lyme disease. Individual case reports have documented improvement with this approach, though no large-scale clinical trials have been conducted to establish a standard antibiotic protocol for Morgellons specifically. Patients with confirmed tick-borne coinfections may receive additional antimicrobial treatment tailored to those organisms.

Why the Controversy Persists

Morgellons occupies an uncomfortable gap in medicine. Patients experience real suffering: open sores, relentless itching, and visible fibers that they can photograph and collect. Being told the condition is psychiatric feels dismissive, especially when peer-reviewed studies have identified bacterial DNA in their skin. At the same time, the CDC’s study found no infectious cause, and antipsychotic medications do resolve symptoms in many cases, which is difficult to explain if the condition is purely infectious.

Part of the problem is that the key studies on both sides have limitations. The CDC study has been criticized for its relatively small sample size and for not testing specifically for Borrelia. The studies linking Morgellons to Lyme disease have been conducted primarily by a small group of researchers, and larger, independent replication has been slow to materialize. The result is a condition where two camps of credentialed scientists look at the same patients and reach opposite conclusions.

For people experiencing these symptoms, the practical reality is that a thorough medical workup matters. Testing for Lyme disease and other tick-borne infections is reasonable given the published associations. So is being open to psychiatric treatment if testing comes back negative, since the evidence for symptom improvement with low-dose antipsychotics is well-documented. What doesn’t help is the assumption, still common in clinical settings, that every patient presenting with fibers should be immediately categorized as delusional without investigation.